- Home
- IVP vs ONVO Comparison
IVP vs ONVO Comparison
Compare IVP & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- ONVO
- Stock Information
- Founded
- IVP 2020
- ONVO 2007
- Country
- IVP United States
- ONVO United States
- Employees
- IVP N/A
- ONVO N/A
- Industry
- IVP Diversified Commercial Services
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IVP Miscellaneous
- ONVO Health Care
- Exchange
- IVP Nasdaq
- ONVO Nasdaq
- Market Cap
- IVP 7.9M
- ONVO 7.2M
- IPO Year
- IVP 2023
- ONVO N/A
- Fundamental
- Price
- IVP $0.24
- ONVO $0.42
- Analyst Decision
- IVP
- ONVO
- Analyst Count
- IVP 0
- ONVO 0
- Target Price
- IVP N/A
- ONVO N/A
- AVG Volume (30 Days)
- IVP 24.7M
- ONVO 102.4K
- Earning Date
- IVP 11-13-2024
- ONVO 11-26-2024
- Dividend Yield
- IVP N/A
- ONVO N/A
- EPS Growth
- IVP N/A
- ONVO N/A
- EPS
- IVP N/A
- ONVO N/A
- Revenue
- IVP $17,054,777.00
- ONVO $103,000.00
- Revenue This Year
- IVP N/A
- ONVO $59.08
- Revenue Next Year
- IVP N/A
- ONVO $18.24
- P/E Ratio
- IVP N/A
- ONVO N/A
- Revenue Growth
- IVP 6.12
- ONVO N/A
- 52 Week Low
- IVP $0.23
- ONVO $0.32
- 52 Week High
- IVP $90.00
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- IVP 33.74
- ONVO 47.62
- Support Level
- IVP $0.23
- ONVO $0.39
- Resistance Level
- IVP $0.26
- ONVO $0.46
- Average True Range (ATR)
- IVP 0.03
- ONVO 0.05
- MACD
- IVP 0.03
- ONVO -0.00
- Stochastic Oscillator
- IVP 4.74
- ONVO 62.27
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.